Redwood Trust Inc (RWT)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Redwood Trust Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 5 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 4.60 $ — 5% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/04/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AAQS
2/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 17.5%
- Exp. sales growth 3Y > 5% -61.6%
- EBIT growth 10Y > 5% 21.4%
- Exp. EBIT growth 3Y > 5% -61.6%
- Net debt < 4x EBIT 20.4x
- EBIT positive, 10Y straight 9
- Max. EBIT decline < 50% 100.0%
- Return on equity > 15% -7.4%
- ROCE > 15% 5.2%
- Expected return > 10% -736.3%
View all AAQS quality stocks · Read the methodology at AlleAktien
Source: fundamental data
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
5 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 28.4% passed
- More than 10% revenue growth is expected for the coming year 20.6% passed
- Share count grows by less than 3% a year 3.6% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -909.7% failed
- Gross margin at 40% or higher and without meaningful erosion 95.6% passed
- Goodwill from acquisitions does not grow faster than revenue 0.1% passed
- Net debt below twice EBITDA 20.2 x EBITDA failed
- Operating cash flow covers the profits of the last three years -17,955 m failed
- Return on capital at 15% or higher, or up versus two years ago 5.2% passed
- Insiders hold at least 10% or are net buyers 1.6% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 28.5% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 8
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 0.94 | 0.74 – 1.07 | 146 | 358.8% | 8 |
| 12/31/2027 | 1.03 | 0.75 – 1.21 | 163 | 10.3% | 8 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.05 | -127.60 | 31 | -45.90 | -21.40 | -854 | -854 |
| 2025: Q1 | 0.12 | -47.10 | 308 | 313.10 | 5.20 | -1,953 | -1,953 |
| 2025: Q2 | -0.74 | -729.80 | 218 | 222.60 | -45.30 | -2,113 | -2,113 |
| 2025: Q3 | -0.06 | -153.30 | 328 | 369.80 | -2.40 | -2,668 | -2,668 |
| 2025: Q4 | 0.16 | – | 211 | 582.50 | 9.50 | -3,361 | -3,361 |
| 2026: Q1 | -0.04 | -136.30 | 408 | 32.50 | -1.30 | -4,508 | -4,508 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 260 | 184 | 131 | 1.34 | -546 | 1,149 | 5,483 |
| 2017 | 239 | 162 | 140 | 1.38 | -1,713 | 1,212 | 7,040 |
| 2018 | 216 | 133 | 120 | 1.09 | -1,612 | 1,349 | 11,937 |
| 2019 | 327 | 212 | 169 | 1.24 | -1,166 | 1,827 | 17,995 |
| 2020 | -318 | -439 | -582 | -5.11 | -505 | 1,111 | 10,355 |
| 2021 | 952 | 769 | 320 | 2.25 | -5,695 | 1,386 | 14,707 |
| 2022 | 523 | 369 | -164 | -1.39 | -139 | 1,084 | 13,031 |
| 2023 | 159 | 11 | -2 | -0.02 | -2,016 | 1,203 | 14,504 |
| 2024 | 1,083 | 915 | 54 | 0.41 | -5,863 | 1,188 | 18,258 |
| 2025 | 1,107 | 1,055 | -70 | -0.54 | -10,095 | 983 | 23,701 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Redwood Trust, Inc. ist zusammen mit seinen Tochtergesellschaften ein Spezialfinanzierungsunternehmen in den USA.
| Employees | 351 |
|---|---|
| Headquarters | Mill Valley, CA |
| Address | One Belvedere Place, 94941 Mill Valley, United States |
| Phone | 415 389 7373 |
| Website | redwoodtrust.com |
| IPO Date | 4. Aug 1995 |
| ISIN | US7580754023 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Christopher J. Abate CPA | CEO & Director | 1980 |
| Dashiell I. Robinson | President & Director | 1980 |
| Brooke E. Carillo | Executive VP & CFO | 1987 |
| Andrew P. Stone J.D. | Executive VP, Chief Legal Officer & Secretary | 1971 |
| Sasha G. Macomber | Chief Human Resource Officer | 1970 |
| Abhinav Asthana | Chief Technology Officer | – |
| John H. Isbrandtsen | MD & Head of Operational Risk | 1962 |
| Carlene A. Graham | President of Sequoia | – |
| Jonathan M. Groesbeck | Head of Business Development & Institutional Sales of Sequoia | – |
| David P. Monks | Managing Director of Finance | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.